Publications Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands
Publications The importance of economic perspective and quantitative approaches in oncology value frameworks of drug selection and shared decision making
Publications Headroom beyond the quality- adjusted life-year: the case of complex pediatric neurology
Publications Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
Publications Treatment patterns, resource utilization, and outcomes among hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Lebanon and Saudi Arabia
Publications Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
Publications Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients
Publications Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
Publications Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-? inhibitors upon achieving stable disease activity in rheumatoid arthritis patients